Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort

Conclusion: Although we cannot rule out an increase in several rare types of EC, our analysis suggests that the overall incidence or risk of EC does not appear to be increased by the presence of BRCA1 or BRCA2 mutations.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gynecologic Oncology Source Type: research